← back to search

Wenchao Gu

Nantong University · CN
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Medicine, Cancer research, Metastasis, Immune system, Cancer, and Adenocarcinoma.
h-index
citations
847
works
20
NIH funding
primary concept
email

Recent publications

Longitudinal MRI‐Driven Multi‐Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer
Advanced Science 2025cited by 28position: middledoi
5’-transfer RNA halve-lysine-CTT as a promising biomarker for early detection of hepatocellular carcinoma
World Journal of Gastrointestinal Oncology 2025cited by 1position: middledoi
Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: Mechanisms and therapeutic prospects
Journal of Advanced Research 2024cited by 54position: middledoi
Using tumor habitat-derived radiomic analysis during pretreatment 18F-FDG PET for predicting KRAS/NRAS/BRAF mutations in colorectal cancer
Cancer Imaging 2024cited by 28position: middledoi
A novel model for predicting postoperative liver metastasis in R0 resected pancreatic neuroendocrine tumors: integrating computational pathology and deep learning-radiomics
Journal of Translational Medicine 2024cited by 18position: middledoi
Enhancing the prediction of symptomatic radiation pneumonitis for locally advanced non-small-cell lung cancer by combining 3D deep learning-derived imaging features with dose–volume metrics: a two-center study
Strahlentherapie und Onkologie 2024cited by 9position: middledoi
Preoperative prediction of lymph node metastasis in colorectal cancer using <sup>18</sup>F‐FDG PET/CT peritumoral radiomics analysis
Medical Physics 2024cited by 5position: middledoi
Dysregulated transfer RNA-derived small RNAs as potential gastric cancer biomarkers
Experimental Biology and Medicine 2024cited by 2position: middledoi
Development and validation of CT-based radiomics deep learning signatures to predict lymph node metastasis in non-functional pancreatic neuroendocrine tumors: a multicohort study
EClinicalMedicine 2023cited by 46position: firstdoi
CoCoSoDa: Effective Contrastive Learning for Code Search
2023cited by 45position: middledoi
Additional file 2 of Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription
Figshare 2023cited by 0position: middledoi
Additional file 1 of Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription
Figshare 2023cited by 0position: middledoi
Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
Frontiers in Immunology 2022cited by 62position: middledoi
<scp>ITGB1</scp> as a prognostic biomarker correlated with immune suppression in gastric cancer
Cancer Medicine 2022cited by 41position: firstdoi
Diagnostic Value, Prognostic Value, and Immune Infiltration of LOX Family Members in Liver Cancer: Bioinformatic Analysis
Frontiers in Oncology 2022cited by 26position: middledoi
Identification and Verification of Potential Biomarkers in Gastric Cancer By Integrated Bioinformatic Analysis
Frontiers in Genetics 2022cited by 21position: middledoi
<i>YKT6</i> , as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration
OncoImmunology 2021cited by 111position: middledoi
METTL3 Is Suppressed by Circular RNA circMETTL3/miR-34c-3p Signaling and Limits the Tumor Growth and Metastasis in Triple Negative Breast Cancer
Frontiers in Oncology 2021cited by 21position: middledoi
Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype
Journal of Thoracic Oncology 2019cited by 282position: middledoi
MiR-19b and miR-20a suppress apoptosis, promote proliferation and induce tumorigenicity of multiple myeloma cells by targeting PTEN
Cancer Biomarkers 2019cited by 47position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Zongcheng Yang · Shandong University5 papers (2021–2023)Takahito Nakajima · Center for Cancer Research3 papers (2023–2023)Lixin Zheng · Shandong University3 papers (2021–2023)Xin Xu · Shandong University3 papers (2021–2023)Zhehao Lyu · Harbin Medical University2 papers (2024–2024)Weiqi Sheng · The First Affiliated Hospital, Sun Yat-sen University2 papers (2022–2024)Yexin Su · Shanghai Medical College of Fudan University2 papers (2024–2024)Chuandong Lang · University of Science and Technology of China2 papers (2023–2023)Jihui Jia · Shandong University2 papers (2023–2023) · 2 papers (2022–2022) · 2 papers (2022–2022)Hongyue Zhao · Harbin Medical University2 papers (2023–2024) · 2 papers (2023–2023)Lei Shen · City Of Hope National Medical Center2 papers (2024–2025)Xinfeng Yao · Nanchang University2 papers (2023–2023) · 2 papers (2023–2023)Yisheng Chen · Fudan University2 papers (2022–2022)Fen Liu · Shandong University2 papers (2021–2023) · 2 papers (2023–2023)Na Hyun Kim · Imperial College Healthcare NHS Trust2 papers (2022–2022)